本页面由Tiger Trade Technology Pte. Ltd.提供服务

Cytek BioSciences

5.31
-0.1200-2.21%
盘后:5.310.00000.00%19:30 EDT
成交量:103.67万
成交额:546.67万
市值:6.90亿
市盈率:-8.43
高:5.42
开:5.42
低:5.12
收:5.43
52周最高:6.21
52周最低:3.31
股本:1.30亿
流通股本:1.03亿
量比:0.46
换手率:1.01%
股息:- -
股息率:- -
每股收益(TTM):-0.6300
每股收益(LYR):-0.5209
净资产收益率:-23.04%
总资产收益率:-6.31%
市净率:2.14
市盈率(LYR):-10.19

数据加载中...

2022/03/14

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/03/02

重要事件披露

8-K - Current report
2022/02/28

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/02/23

重要事件披露

8-K - Current report
2022/02/17

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/06

重要事件披露

8-K - Current report
2021/09/02

季度报告

Cytek Biosciences, Inc.
2021/07/29

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/07/27

重要事件披露

8-K - Current report
2021/07/27

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/07/27

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/07/23

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/07/20

SEC问询函

CORRESP [Cover] - Correspondence
2021/07/19

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/07/14

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/07/13

SEC问询函

CORRESP [Cover] - Correspondence
2021/07/02

SEC问询函

CORRESP [Cover] - Correspondence